WINNIPEG, April 15 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced that Fudan University Huashan Hospital in Shanghai, China has selected IMRISneuro for its expanding neurosurgical department. Huashan Hospital will be the first in Asia to take delivery of the new 3 Tesla version of IMRISneuro: a fully integrated operating room that provides high-quality MR images during a procedure without moving the patient. The project includes IMRISmatrix - a fully integrated surgical information management system.
The announcement of Huashan Hospital marks IMRIS' second project in China and follows on the heels of the official opening of the 1.5 Tesla IMRISneuro suite at PLA 301 Hospital in Beijing. David Graves, President and CEO of IMRIS, shared his excitement about the company's growth in Asia. "Installing our technology in these two leading neurosurgical sites is strong evidence of the growing appreciation of the value of IMRISneuro", said Mr. Graves. "IMRIS is looking forward to fast acceptance and growth of MR-guided neurosurgery in China".
IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons for use in world-class neuroscience centers.
|SOURCE IMRIS Inc.|
Copyright©2009 PR Newswire.
All rights reserved